Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Critical Care
Published in: Critical Care 3/2008

Open Access 01-06-2008 | Research

Intensive care outcomes in bone marrow transplant recipients: a population-based cohort analysis

Authors: Damon C Scales, Deva Thiruchelvam, Alexander Kiss, William J Sibbald, Donald A Redelmeier

Published in: Critical Care | Issue 3/2008

Login to get access

Abstract

Introduction

Intensive care unit (ICU) admission for bone marrow transplant recipients immediately following transplantation is an ominous event, yet the survival of these patients with subsequent ICU admissions is unknown. Our objective was to determine the long-term outcome of bone marrow transplant recipients admitted to an ICU during subsequent hospitalizations.

Methods

We conducted a population-based cohort analysis of all adult bone marrow transplant recipients who received subsequent ICU care in Ontario, Canada from 1 January 1992 to 31 March 2002. The primary endpoint was mortality at 1 year.

Results

A total of 2,653 patients received bone marrow transplantation; 504 of which received ICU care during a subsequent hospitalization. Patients receiving any major procedure during their ICU stay had higher 1-year mortality than those patients who received no ICU procedure (87% versus 44%, P < 0.0001). Death rates at 1 year were highest for those receiving mechanical ventilation (87%), pulmonary artery catheterization (91%), or hemodialysis (94%). In combination, the strongest independent predictors of death at 1 year were mechanical ventilation (odds ratio, 7.4; 95% confidence interval, 4.8 to 11.4) and hemodialysis (odds ratio, 8.7; 95% confidence interval, 2.1 to 36.7), yet no combination of procedures uniformly predicted 100% mortality.

Conclusion

The prognosis of bone marrow transplant recipients receiving ICU care during subsequent hospitalizations is very poor but should not be considered futile.
Appendix
Available only for authorised users
Literature
1.
Clift RA, Buckner CD, Appelbaum FR, Bearman SI, Petersen FB, Fisher LD, Anasetti C, Beatty P, Bensinger WI, Doney K: Allogeneic marrow transplantation in patients with acute myeloid leukemia in first remission: a randomized trial of two irradiation regimens. Blood 1990, 76: 1867-1871.PubMed
2.
Kernan NA, Bartsch G, Ash RC, Beatty PG, Champlin R, Filipovich A, Gajewski J, Hansen JA, Henslee-Downey J, McCullough J: Analysis of 462 transplantations from unrelated donors facilitated by the National Marrow Donor Program. N Engl J Med 1993, 328: 593-602. 10.1056/NEJM199303043280901CrossRefPubMed
3.
Aversa F, Tabilio A, Velardi A, Cunningham I, Terenzi A, Falzetti F, Ruggeri L, Barbabietola G, Aristei C, Latini P, Reisner Y, Martelli MF: Treatment of high-risk acute leukemia with T-cell-depleted stem cells from related donors with one fully mismatched HLA haplotype. N Engl J Med 1998, 339: 1186-1193. 10.1056/NEJM199810223391702CrossRefPubMed
4.
Horak DA, Forman SJ: Critical care of the hematopoietic stem cell patient [review, 122 refs]. Crit Care Clin 2001, 17: 671-695. 10.1016/S0749-0704(05)70203-7CrossRefPubMed
5.
Kotloff RM, Ahya VN, Crawford SW: Pulmonary complications of solid organ and hematopoietic stem cell transplantation. Am J Respir Crit Care Med 2004, 170: 22-48. 10.1164/rccm.200309-1322SOCrossRefPubMed
6.
Gordon B, Haire W, Ruby E, Kotulak G, Stephens L, Kessinger A, Armitage J: Factors predicting morbidity following hematopoietic stem cell transplantation. Bone Marrow Transplant 1997, 497-501. 10.1038/sj.bmt.1700684
7.
Haire WD, Ruby EI, Gordon BG, Patil KD, Stephens LC, Kotulak GD, Reed EC, Vose JM, Bierman PJ, Kessinger A: Multiple organ dysfunction syndrome in bone marrow transplantation. JAMA 1995, 274: 1289-1295. 10.1001/jama.274.16.1289CrossRefPubMed
8.
Ho VT, Weller E, Lee SJ, Alyea EP, Antin JH, Soiffer RJ: Prognostic factors for early severe pulmonary complications after hematopoietic stem cell transplantation [review, 40 refs]. Biol Blood Marrow Transplant 2001, 7: 223-229. 10.1053/bbmt.2001.v7.pm11349809CrossRefPubMed
9.
Bach PB, Schrag D, Nierman DM, Horak D, White P Jr, Young JW, Groeger JS: Identification of poor prognostic features among patients requiring mechanical ventilation after hematopoietic stem cell transplantation. Blood 2001, 98: 3234-3240. 10.1182/blood.V98.12.3234CrossRefPubMed
10.
Price KJ, Thall PF, Kish SK, Shannon VR, Andersson BS: Prognostic indicators for blood and marrow transplant patients admitted to an intensive care unit. Am J Respir Crit Care Med 1998, 158: 876-884.CrossRefPubMed
11.
Pene F, Aubron C, Azoulay E, Blot F, Thiery G, Raynard B, Schlemmer B, Nitenberg G, Buzyn A, Arnaud P, Socie G, Mira JP: Outcome of critically ill allogeneic hematopoietic stem-cell transplantation recipients: a reappraisal of indications for organ failure supports. J Clin Oncol 2006, 24: 643-649. 10.1200/JCO.2005.03.9073CrossRefPubMed
12.
Crawford SW, Petersen FB: Long-term survival from respiratory failure after marrow transplantation for malignancy. Am Rev Respir Dis 1992, 145: 510-514.CrossRefPubMed
13.
Faber-Langendoen K, Caplan AL, McGlave PB: Survival of adult bone marrow transplant patients receiving mechanical ventilation: a case for restricted use. Bone Marrow Transplant 1993, 12: 501-507.PubMed
14.
Jackson SR, Tweeddale MG, Barnett MJ, Spinelli JJ, Sutherland HJ, Reece DE, Klingemann HG, Nantel SH, Fung HC, Toze CL, Phillips GL, Shepherd JD: Admission of bone marrow transplant recipients to the intensive care unit: outcome, survival and prognostic factors. Bone Marrow Transplant 1998, 21: 697-704. 10.1038/sj.bmt.1701158CrossRefPubMed
15.
Scott PH, Morgan TJ, Durrant S, Boots RJ: Survival following mechanical ventilation of recipients of bone marrow transplants and peripheral blood stem cell transplants. Anaesth Intensive Care 2002, 30: 289-294.PubMed
16.
Soubani AO, Kseibi E, Bander JJ, Klein JL, Khanchandani G, Ahmed HP, Guzman JA: Outcome and prognostic factors of hematopoietic stem cell transplantation recipients admitted to a medical ICU [review, 34 refs]. Chest 2004, 126: 1604-1611. 10.1378/chest.126.5.1604CrossRefPubMed
17.
Klingemann HG: Mechanical ventilation for bone marrow transplant patients: when does it become futile? [Comment]. Crit Care Med 2000, 28: 899-900. 10.1097/00003246-200003000-00057CrossRefPubMed
18.
Perry AR, Rivlin MM, Goldstone AH: Bone marrow transplant patients with life-threatening organ failure: when should treatment stop? J Clin Oncol 1999, 17: 298-303.PubMed
19.
Weinacker A: Intensive care unit support of hematopoietic stem cell transplant recipients: a case for cautious optimism [comment]. Crit Care Med 2003, 31: 1873-1875. 10.1097/01.CCM.0000065685.13578.EECrossRefPubMed
20.
Dowdy DW, Needham DM, Mendez-Tellez PA, Herridge MS, Pronovost PJ: Studying outcomes of intensive care unit survivors: the role of the cohort study. Intensive Care Med 2005, 31: 914-921. 10.1007/s00134-005-2657-6CrossRefPubMed
21.
Williams JI, Young W: A summary of studies on the quality of health care administrative databases in Canada. In Patterns of Health Care in Ontario: The ICES Practice Atlas. Edited by: Goel V, Williams JI, Anderson GM, Blackstien-Hirsch P, Fooks C, Naylor CD. Ottawa, ON: Canadian Medical Association; 1996:339-345.
22.
Iron K, Goel V, Williams JI: Concordance with Hospital Discharge Abstracts and Physician Claims for Surgical Procedures in Ontario. ICES Working Paper Series Reports 42. North York, ON: Institute for Clinical Evaluative Sciences; 1995.
23.
Bell CM, Redelmeier DA: Mortality among patients admitted to hospitals on weekends as compared with weekdays. N Engl J Med 2001, 345: 663-668. 10.1056/NEJMsa003376CrossRefPubMed
24.
Williams JI, Young W: Inventory of Studies on the Accuracy of Canadian Health Administrative Databases. Technical report. Ottawa, ON: Institute for Clinical Evaluative Sciences; 1996.
25.
Hackam DG, Mamdani M, Li P, Redelmeier DA: Statins and sepsis in patients with cardiovascular disease: a population-based cohort analysis. Lancet 2006, 367: 413-418. 10.1016/S0140-6736(06)68041-0CrossRefPubMed
26.
Redelmeier D, Scales D, Kopp A: Beta blockers for elective surgery in elderly patients: population based, retrospective cohort study. BMJ 2005, 331: 932-935. 10.1136/bmj.38603.746944.3APubMedCentralCrossRefPubMed
27.
Scales DC, Guan J, Martin CM, Redelmeier DA: Administrative data accurately identified intensive care unit admissions in Ontario. J Clin Epidemiol 2006, 59: 802-807. 10.1016/j.jclinepi.2005.11.015CrossRefPubMed
28.
Waikar SS, Wald R, Chertow GM, Curhan GC, Winkelmayer WC, Liangos O, Sosa MA, Jaber BL: Validity of International Classification of Diseases, Ninth Revision, Clinical Modification Codes for Acute Renal Failure. J Am Soc Nephrol 2006, 17: 1688-1694. 10.1681/ASN.2006010073CrossRefPubMed
29.
Myers RP, Leung Y, Shaheen AA, Li B: Validation of ICD-9-CM/ICD-10 coding algorithms for the identification of patients with acetaminophen overdose and hepatotoxicity using administrative data. BMC Health Serv Res 2007, 7: 159-166. 10.1186/1472-6963-7-159PubMedCentralCrossRefPubMed
30.
Rubenfeld GD, Crawford SW: Withdrawing life support from mechanically ventilated recipients of bone marrow transplants: a case for evidence-based guidelines [see comment]. Ann Intern Med 1996, 125: 625-633.CrossRefPubMed
31.
Hennessy BJ, White M, Crotty GM: Predicting death in mechanically ventilated recipients of bone marrow transplants. [Letter]. Ann Intern Med 1997, 127: 88.CrossRefPubMed
32.
Schneiderman LJ, Jecker NS, Jonsen AR: Medical futility: response to critiques. Ann Intern Med 1996, 125: 669-674.CrossRefPubMed
33.
Shemie SD: Bone marrow transplantation and intensive care unit admission: what really matters? [Comment]. Crit Care Med 2003, 31: 1579. 10.1097/01.CCM.0000065680.32292.44CrossRefPubMed
34.
Sackett DL, Haynes RB, Guyatt GH, Tugwell P: Deciding on the best therapy. In Clinical Epidemiology: A Basic Science for Clinical Medicine. Edited by: Sackett DL, Haynes RB, Guyatt GH, Tugwell P. Toronto: Little, Brown and Company; 1991:187-248.
35.
Afessa B, Tefferi A, Dunn WF, Litzow MR, Peters SG: Intensive care unit support and Acute Physiology and Chronic Health Evaluation III performance in hematopoietic stem cell transplant recipients [see comment]. Crit Care Med 2003, 31: 1715-1721. 10.1097/01.CCM.0000065761.51367.2DCrossRefPubMed
36.
37.
Logan BR, Klein JP, Zhang MJ: Comparing treatments in the presence of crossing survival curves: an application to bone marrow transplantation. Biometrics, in press.
38.
Bishop M, Logan B, Gandham S, Bolwell B, Cahn J, Lazarus H, Litzow MR, Marks DI, Wiernik PH, McCarthy PL, Russell JA, Miller CB, Sierra J, Milone G, Keating A, Loberiza FR, Giralt S, Horowitz MM, Weisdorf DJ: Long-term outcomes of adults with acute lymphoblastic leukemia after autologous or unrelated donor bone marrow transplantation: a comparative analysis by the National Marrow Donor Program for International Blood and Marrow Transplant Research. Bone Marrow Transplant 2008, 41: 635-642. 10.1038/sj.bmt.1705952PubMedCentralCrossRefPubMed
39.
Schimmer AD, Jamal S, Messner H, Keating A, Meharchand J, Huebsch L, Walker I, Benger A, Gluck S, Smith A: Allogeneic or autologous bone marrow transplantation (BMT) for non-Hodgkin's lymphoma (NHL): results of a provincial strategy. Ontario BMT Network, Canada. Bone Marrow Transplant 2000, 26: 859-864. 10.1038/sj.bmt.1702625CrossRefPubMed
40.
Zittoun RA, Mandelli F, Willemze R, de WT, Labar B, Resegotti L, Leoni F, Damasio E, Visani G, Papa G, Caronia F, Hayat M, Stryckmans P, Rotoli B, Leoni P, Peetermans ME, Dardenne M, Luce Vegna M, Concetta Petti M, Solbu G, Suciu S: Autologous or allogeneic bone marrow transplantation compared with intensive chemotherapy in acute myelogenous leukemia. European Organization for Research and Treatment of Cancer (EORTC) and the Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto (GIMEMA) Leukemia Cooperative Groups. N Engl J Med 1995, 332: 217-223. 10.1056/NEJM199501263320403CrossRefPubMed
41.
Dowdy DW, Eid MP, Sedrakyan A, Mendez-Tellez PA, Pronovost PJ, Herridge MS, Needham DM: Quality of life in adult survivors of critical illness: a systematic review of the literature. Intensive Care Med 2005, 31: 611-620. 10.1007/s00134-005-2592-6CrossRefPubMed
42.
Herridge MS: Long-term outcomes after critical illness. Curr Opin Crit Care 2002, 8: 331-336. 10.1097/00075198-200208000-00010CrossRefPubMed
Metadata
Title
Intensive care outcomes in bone marrow transplant recipients: a population-based cohort analysis
Authors
Damon C Scales
Deva Thiruchelvam
Alexander Kiss
William J Sibbald
Donald A Redelmeier
Publication date
01-06-2008
Publisher
BioMed Central
Published in
Critical Care / Issue 3/2008
Electronic ISSN: 1364-8535
DOI
https://doi.org/10.1186/cc6923

Other articles of this Issue 3/2008

Critical Care 3/2008 Go to the issue

Review

Clinical review: Influenza pandemic – physicians and their obligations

Research

Randomized trial comparing daily interruption of sedation and nursing-implemented sedation algorithm in medical intensive care unit patients

Commentary

Moving beyond tight glucose control to safe effective glucose control

Research

Resource use and outcome in critically ill patients with hematological malignancy: a retrospective cohort study

Research

A phase 1 trial of nebulised heparin in acute lung injury

Research

Quantification of lean and fat tissue repletion following critical illness: a case report